Sponsor content
2 result(s) found, displaying 1 to 2
-
Australian public assessment report (AusPar)Pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat which has been approved for the treatment of adults with late onset Pompe disease (acid α-glucosidase [GAA] deficiency).
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Migalastat